The role of tyrosine kinase inhibitors in tuberous sclerosis

Br J Haematol. 2009 Oct;147(1):152-3. doi: 10.1111/j.1365-2141.2009.07826.x. Epub 2009 Jul 15.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • Female
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Piperazines / therapeutic use
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrimidines / therapeutic use
  • Treatment Failure
  • Tuberous Sclerosis / drug therapy*

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate